Manufacturing Standards Key to Advancing Cellular and Gene Therapies – Pharmaceutical Technology Magazine
|
Manufacturing Standards Key to Advancing Cellular and Gene Therapies
Pharmaceutical Technology Magazine Similar issues have been discussed related to applications for Kite Pharma's therapy for aggressive non-Hodgkin lymphoma and Spark Therapeutics' new gene therapy to treat a rare condition causing blindness, which are moving through the FDA approval … |
